Ethical approval was not considered necessary given the use of the identified data
In 2021, BPI was served with a Form 483 letter from the FDA, alleging the company was using improper equipment and procedures and failing to vet suppliers adequately
Weight-loss drugs may not be suitable for all and can be associated with side effects such as constipation (difficulty passing stools), nausea, vomiting, headache, fatigue, diarrhea, mood changes, palpitations (irregular heartbeat), etc
These headaches can vary from mild to intense and may be temporary or persist throughout the treatment period
For patients on semaglutide who receive formulations with B12, the semaglutide B12 dosage chart and the compounded semaglutide with B12 dosage chart cover those specific formulations